Login | Register

First Drug To Help Melanoma Of The Eye

AstraZeneca's experimental drug, selumetinib, is the first targeted medication to show a significant clinical benefit for patients with melanoma of the eye (metastatic uveal melanoma), researchers from the Memorial Sloan-Kettering Cancer Center explained at the 49th annual meeting of the American Society of Clinical Oncology (ASCO), in Chicago, Illinois...

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *